Insulin aspart, recombinant Subcutaneous and Timentin Add-Vantage
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Timentin Add-Vantage and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: clavulanate / ticarcillin
Brand name: Timentin
Synonyms: Timentin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Timentin Injection
- Insulin aspart, recombinant Subcutaneous-Timentin Novaplus
- Insulin aspart, recombinant Subcutaneous-Timolide
- Insulin aspart, recombinant Subcutaneous-Timolol
- Insulin aspart, recombinant Subcutaneous-Timolol (Systemic)
- Insulin aspart, recombinant Subcutaneous-Timolol and hydrochlorothiazide
- Timentin Add-Vantage-Insulin degludec
- Timentin Add-Vantage-Insulin Degludec (U-100) Prefilled Pens
- Timentin Add-Vantage-Insulin Degludec (U-100) Vials
- Timentin Add-Vantage-Insulin Degludec (U-200) Prefilled Pens
- Timentin Add-Vantage-Insulin degludec and liraglutide
- Timentin Add-Vantage-Insulin degludec and liraglutide Subcutaneous